search
Back to results

Intra Dialytic Parenteral Nutrition and Nutritional Gap Nutritional Gap Identified by Indirect Calorimetry (DiaPaNIC)

Primary Purpose

Chronic Kidney Diseases, Protein Energy Wasting

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Indirect Calorimetry
Bio-electrical Impedance Analysis (BIA)
Nutritional assessments
Sponsored by
Universitair Ziekenhuis Brussel
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Chronic Kidney Diseases focused on measuring Indirect Calorimetry, Parenteral Nutrition, Hemodialysis

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patient on intermittent hemodialysis
  • Protein-Energy Wasting defined as 5% within 3 months or 10% within 6 months (not due to water loss, established at the discretion of the treating physician)

Exclusion Criteria:

  • Pregnancy
  • Contra-indications for the use of indirect calorimetry as stated by the AARC (oxygen therapy for COPD,...)
  • Metabolic diseases

Sites / Locations

    Arms of the Study

    Arm 1

    Arm Type

    Experimental

    Arm Label

    Assessments

    Arm Description

    In this single-arm trial, each participant undergoes the following measurements/assessments: Physical: Body weight (before and after dialysis), length Biophysical: NRS2002, GLIM, Bio-electrical Impedance Analysis Metabolic: Indirect Calorimetry Nutritional: dietary anamnesis, 3-days nutritional diary

    Outcomes

    Primary Outcome Measures

    Caloric adequacy
    caloric intake (kcal/day) and caloric need (kcal/day) (see secondary outcomes) will be combined to report caloric adequacy according to this equation: [sum of percentage of caloric intake/caloric need]/total of evaluable nutrition days (%)

    Secondary Outcome Measures

    Protein adequacy
    protein intake (from nutritional assessments)/protein need (%)
    Fat Mass (FM)
    measured by Bio-electrical Impedance Analysis (BIA) (kg and %);
    Fat Free Mass (FFM)
    measured by Bio-electrical Impedance Analysis (BIA) (kg and %);
    Phase angle
    measured by Bio-electrical Impedance Analysis (BIA) (kg and %);
    Body weight
    Body weight (kg)
    Compatibility between the caloric gap and PN ready to use formulae on the market
    Comparison between individual caloric need of patients and ready to use PN formulae (PeriOlimel N4E (Baxter), Olimel N5E (Baxter), Olimel N7E (Baxter), Olimel N9/N9E (Baxter), Olimel N12/N12E (Baxter), SMOFKabiven Ex-tra Amino (Fresenius), SMOFKabiven peripheral (Fresenius), SMOFKabiven Peri Low Osmo (Fresenius), SMOFKabiven E/EF (Frese-nius), Omegomel Peri (Baxter), Nutriflex Omega Special (B Braun); based on caloric content per bag of PN on the market (Unit of measurement: portion of PN bag (%) needed to close the caloric gap)
    Mean caloric intake
    (kcal/day) from nutritional assessments (3-day nutritional diary and nutritional anamnesis
    Caloric need
    (kcal/day): Resting Energy Expenditure (REE) measured by Indirect Calorimetry (IC)
    Mean protein intake
    g/day): from nutritional assessments (3-day nutritional diary and nutritional anamnesis
    Barriers for patients for use of IDPN
    "would you agree to IDPN if your health condition required it? Please elaborate"
    Barriers for dialysis nurses and nephrologists for use of IDPN
    "Are logistical and practical barriers holding you back from prescribing or administering IDPV? Please elaborate."

    Full Information

    First Posted
    August 30, 2022
    Last Updated
    June 2, 2023
    Sponsor
    Universitair Ziekenhuis Brussel
    Collaborators
    Baxter Healthcare Corporation
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT05568914
    Brief Title
    Intra Dialytic Parenteral Nutrition and Nutritional Gap Nutritional Gap Identified by Indirect Calorimetry
    Acronym
    DiaPaNIC
    Official Title
    Intra Dialytic Parenteral Nutrition During Intermittent Hemodialysis Can Close the Nutritional Gap Identified by Indirect Calorimetry: a Pilot and Feasibility Study
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    July 2022
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    September 1, 2023 (Anticipated)
    Primary Completion Date
    August 31, 2024 (Anticipated)
    Study Completion Date
    August 31, 2024 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Universitair Ziekenhuis Brussel
    Collaborators
    Baxter Healthcare Corporation

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    Renal failure is a relevant condition as the incidence of patients treated with intermittent dialysis continues to grow each year. One of the strongest predictors of mortality in these patients is Protein-Energy Wasting (PEW). Optimal nutritional support, combined with physical exercise may be able to improve the physical condition objectified as muscle wasting and weakness. Correct nutritional support must aim to supplement the correct combination of protein and caloric needs. Although no other way exist than predicting formula to assess protein need, predicting formula don't seem to capture the individual caloric need of the patients. The gold standard to assess caloric need by measuring Resting Energy Expenditure (REE) is indirect calorimetry. Even when caloric and protein targets are defined, intake remains a challenge because of intake restriction in dietary patterns. This is why intradialytic parenteral nutrition (IDPN) can play an crucial role for closing the nutritional gap. Whether IDPN guided by indirect calorimetric measurements of metabolism can close the gap when oral intake fails, remains an unanswered question.
    Detailed Description
    Renal failure is a relevant condition as the incidence of patients treated with renal replacement therapy and specifically intermittent dialysis, continues to grow each year. In 2021 up to 4845 patients required intermittent dialysis in Flanders, Belgium. Weight loss and homeostatic disturbances of energy and protein balances are often present in Chronic Kidney disease (CKD) and end-stage renal disease (ESRD).The international society of renal nutrition and metabolism defines Protein-Energy Wasting (PEW) as the state of nutritional and metabolic disorders in patients with CKD and ESRD, characterized by simultaneous loss of systemic body protein and energy stores. PEW is one of the strongest predictors of mortality in CKD patients. Up tot 54% of adults undergoing chronic intermittent haemodialysis (IHD) suffer from PEW due to a combination of the disease and therapy. Adequate nutritional therapy can reverse the negative impact of PEW. Optimal nutritional support, next to physical exercise may be able to improve the physical condition objectified as muscle wasting and weakness. Correct nutritional support must aim to supplement the correct combination of protein and caloric after assessing the needs and intake of different nutrients. Although no other way exist than predicting formula to assess protein need, predicting formula don't seem to capture the individual caloric need of the patients. The gold standard to assess caloric need by measuring Resting Energy Expenditure (REE) is indirect calorimetry. This technique measures the individual VCO2 and VO2 and after integrating it into the Weir equation it calculates REE. Even when caloric and protein target are defined, intake remains a challenge because of intake restriction in dietary patterns. This is why intradialytic parenteral nutrition (IDPN) can play an crucial role for closing the nutritional gap. In clinical practice, in 38% of dialysis patients, IDPN is used. The most common IDPN were triple phase bags. Whether IDPN guided by indirect calorimetric measurements of metabolism can close the gap when oral intake fails, remains an unanswered question.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Chronic Kidney Diseases, Protein Energy Wasting
    Keywords
    Indirect Calorimetry, Parenteral Nutrition, Hemodialysis

    7. Study Design

    Primary Purpose
    Supportive Care
    Study Phase
    Not Applicable
    Interventional Study Model
    Single Group Assignment
    Masking
    None (Open Label)
    Allocation
    N/A
    Enrollment
    20 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Assessments
    Arm Type
    Experimental
    Arm Description
    In this single-arm trial, each participant undergoes the following measurements/assessments: Physical: Body weight (before and after dialysis), length Biophysical: NRS2002, GLIM, Bio-electrical Impedance Analysis Metabolic: Indirect Calorimetry Nutritional: dietary anamnesis, 3-days nutritional diary
    Intervention Type
    Device
    Intervention Name(s)
    Indirect Calorimetry
    Other Intervention Name(s)
    Q-NRG Metabolic Monitor, COSMED
    Intervention Description
    Indirect Calorimetry (Q-NRG Metabolic Monitor, COSMED) is performed to determine the Resting Energy Expenditure before hemodialysis.
    Intervention Type
    Device
    Intervention Name(s)
    Bio-electrical Impedance Analysis (BIA)
    Other Intervention Name(s)
    BIA101/BIVA, Akern
    Intervention Description
    Bio-electrical Impedance Analysis (BIA101/BIVA, Akern) is used to analyse the body composition (Fat Mass, Fat Free Mass, Phase Angle).
    Intervention Type
    Other
    Intervention Name(s)
    Nutritional assessments
    Other Intervention Name(s)
    Dietary anamnesis, Nutritional diary
    Intervention Description
    The Nutritional assessments consist of a dietary anamnesis and a 3-day nutritional diary to determine the nutritional (caloric and protein) intake of the participants.
    Primary Outcome Measure Information:
    Title
    Caloric adequacy
    Description
    caloric intake (kcal/day) and caloric need (kcal/day) (see secondary outcomes) will be combined to report caloric adequacy according to this equation: [sum of percentage of caloric intake/caloric need]/total of evaluable nutrition days (%)
    Time Frame
    Pre-dialysis
    Secondary Outcome Measure Information:
    Title
    Protein adequacy
    Description
    protein intake (from nutritional assessments)/protein need (%)
    Time Frame
    Pre-dialysis
    Title
    Fat Mass (FM)
    Description
    measured by Bio-electrical Impedance Analysis (BIA) (kg and %);
    Time Frame
    20-30 minutes after dialysis
    Title
    Fat Free Mass (FFM)
    Description
    measured by Bio-electrical Impedance Analysis (BIA) (kg and %);
    Time Frame
    20-30 minutes after dialysis
    Title
    Phase angle
    Description
    measured by Bio-electrical Impedance Analysis (BIA) (kg and %);
    Time Frame
    20-30 minutes after dialysis
    Title
    Body weight
    Description
    Body weight (kg)
    Time Frame
    before and after hemodialysis
    Title
    Compatibility between the caloric gap and PN ready to use formulae on the market
    Description
    Comparison between individual caloric need of patients and ready to use PN formulae (PeriOlimel N4E (Baxter), Olimel N5E (Baxter), Olimel N7E (Baxter), Olimel N9/N9E (Baxter), Olimel N12/N12E (Baxter), SMOFKabiven Ex-tra Amino (Fresenius), SMOFKabiven peripheral (Fresenius), SMOFKabiven Peri Low Osmo (Fresenius), SMOFKabiven E/EF (Frese-nius), Omegomel Peri (Baxter), Nutriflex Omega Special (B Braun); based on caloric content per bag of PN on the market (Unit of measurement: portion of PN bag (%) needed to close the caloric gap)
    Time Frame
    through study completion or one year, whichever is sooner
    Title
    Mean caloric intake
    Description
    (kcal/day) from nutritional assessments (3-day nutritional diary and nutritional anamnesis
    Time Frame
    pre-dialysis
    Title
    Caloric need
    Description
    (kcal/day): Resting Energy Expenditure (REE) measured by Indirect Calorimetry (IC)
    Time Frame
    pre-dialysis
    Title
    Mean protein intake
    Description
    g/day): from nutritional assessments (3-day nutritional diary and nutritional anamnesis
    Time Frame
    pre-dialysis
    Title
    Barriers for patients for use of IDPN
    Description
    "would you agree to IDPN if your health condition required it? Please elaborate"
    Time Frame
    pre-dialysis
    Title
    Barriers for dialysis nurses and nephrologists for use of IDPN
    Description
    "Are logistical and practical barriers holding you back from prescribing or administering IDPV? Please elaborate."
    Time Frame
    throughout the duration of the trial
    Other Pre-specified Outcome Measures:
    Title
    Descriptive outcomes
    Description
    age, sex, category of kidney disease, comorbidities, dialysis vintage (years)
    Time Frame
    pre-dialysis
    Title
    Dialysis type
    Description
    (from medical file)
    Time Frame
    During dialysis
    Title
    Delta REE between predicting formula and indirect calorimetry
    Description
    Difference in energy need as calculated using standard formula and measured using IC
    Time Frame
    Pre-dialysis
    Title
    Vascular access type
    Description
    (from medical file)
    Time Frame
    during dialysis
    Title
    Dialysis blood flow rate
    Description
    (from medical file)
    Time Frame
    During dialysis
    Title
    Hemodialysis treatment adequacy (kt/V)
    Description
    (from medical file)
    Time Frame
    During dialysis

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Patient on intermittent hemodialysis Protein-Energy Wasting defined as 5% within 3 months or 10% within 6 months (not due to water loss, established at the discretion of the treating physician) Exclusion Criteria: Pregnancy Contra-indications for the use of indirect calorimetry as stated by the AARC (oxygen therapy for COPD,...) Metabolic diseases
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Elisabeth De Waele, MD, PhD
    Phone
    +3224763354
    Email
    elisabeth.dewaele@uzbrussel.be
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Elisabeth De Waele, MD, PhD
    Organizational Affiliation
    Universitair Ziekenhuis Brussel
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    No

    Learn more about this trial

    Intra Dialytic Parenteral Nutrition and Nutritional Gap Nutritional Gap Identified by Indirect Calorimetry

    We'll reach out to this number within 24 hrs